BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers 2017;3:17077. [PMID: 29072302 DOI: 10.1038/nrdp.2017.77] [Cited by in Crossref: 181] [Cited by in F6Publishing: 151] [Article Influence: 36.2] [Reference Citation Analysis]
Number Citing Articles
1 Ishay A, Touma E, Vornicova O, Dodiuk-Gad R, Goldman T, Bisharat N. Ectopic Cushing's syndrome in a patient with metastatic Merkel cell carcinoma: A case report. World J Clin Cases 2022; 10(22): 7989-7993 [DOI: 10.12998/wjcc.v10.i22.7989] [Reference Citation Analysis]
2 Pająk J, Szepietowski JC, Nowicka D. Prevention of Ageing-The Role of Micro-Needling in Neck and Cleavage Rejuvenation: A Narrative Review. Int J Environ Res Public Health 2022;19:9055. [PMID: 35897441 DOI: 10.3390/ijerph19159055] [Reference Citation Analysis]
3 Moens U. Role of Signaling Pathways in the Viral Life Cycle 2.0. Int J Mol Sci 2022;23:7857. [PMID: 35887205 DOI: 10.3390/ijms23147857] [Reference Citation Analysis]
4 Drexler K, Schwertner B, Haerteis S, Aung T, Berneburg M, Geissler EK, Mycielska ME, Haferkamp S. The Role of Citrate Homeostasis in Merkel Cell Carcinoma Pathogenesis. Cancers 2022;14:3425. [DOI: 10.3390/cancers14143425] [Reference Citation Analysis]
5 Lu J, Li Y, Wang J. Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review. Front Cell Infect Microbiol 2022;12:916506. [DOI: 10.3389/fcimb.2022.916506] [Reference Citation Analysis]
6 Legrand M, Tallet A, Guyétant S, Samimi M, Ortonne N, Kervarrec T. CD5 expression in Merkel cell carcinoma and extracutaneous neuroendocrine carcinomas. Pathology 2022:S0031-3025(22)00180-5. [PMID: 35835644 DOI: 10.1016/j.pathol.2022.04.007] [Reference Citation Analysis]
7 Ananthapadmanabhan V, Frost TC, Soroko KM, Knott A, Magliozzi BJ, Gokhale PC, Tirunagaru VG, Doebele RC, DeCaprio JA. Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma. JCI Insight 2022;7:e160513. [PMID: 35801592 DOI: 10.1172/jci.insight.160513] [Reference Citation Analysis]
8 Tan Y, Qi F, Yao A, Zhang Y, Zhang X. Merkel Cell Carcinoma on the Forearm: A Case Report and Literature Review. Clin Cosmet Investig Dermatol 2022;15:1087-90. [PMID: 35726233 DOI: 10.2147/CCID.S361844] [Reference Citation Analysis]
9 Cilento MA, Klein O, Egan E, Roberts-Thomson R. Talimogene laherparepvec resulting in near-complete response in a patient with treatment-refractory Merkel cell carcinoma. Australas J Dermatol 2022. [PMID: 35666757 DOI: 10.1111/ajd.13881] [Reference Citation Analysis]
10 Spada F, Bossi P, Caracò C, Sileni VC, Dei Tos AP, Fazio N, Grignani G, Maio M, Quaglino P, Queirolo P, Ascierto PA; DELPHI Panel Members. Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel. J Immunother Cancer 2022;10:e004742. [PMID: 35701070 DOI: 10.1136/jitc-2022-004742] [Reference Citation Analysis]
11 García-mesa Y, Martín-sanz R, García-piqueras J, Cobo R, Muñoz-bravo S, García-suárez O, Martín-biedma B, Vega JA, Feito J. Merkel Cell Carcinoma Display PIEZO2 Immunoreactivity. JPM 2022;12:894. [DOI: 10.3390/jpm12060894] [Reference Citation Analysis]
12 Ferrándiz-Pulido C, Gómez-Tomás A, Llombart B, Mendoza D, Marcoval J, Piaserico S, Baykal C, Bouwes-Bavinck JN, Rácz E, Kanitakis J, Harwood CA, Cetkovská P, Geusau A, Del Marmol V, Masferrer E, Orte Cano C, Ricar J, de Oliveira WR, Salido-Vallejo R, Ducroux E, Gkini MA, López-Guerrero JA, Kutzner H, Kempf W, Seçkin D. Clinicopathological features, MCPyV status and outcomes of Merkel cell carcinoma in solid-organ transplant recipients: a retrospective, multicentre cohort study. J Eur Acad Dermatol Venereol 2022. [PMID: 35607918 DOI: 10.1111/jdv.18256] [Reference Citation Analysis]
13 Cartwright JK, Snyder DH, Moreno FG. Development of metastatic Merkel cell carcinoma following the excision of same‐sided recurrent auricular melanoma. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5891] [Reference Citation Analysis]
14 Zebardast A, Latifi T, shirzad M, Goodarzi G, Ebrahimi Fana S, Samavarchi Tehrani S, Yahyapour Y. Critical involvement of circular RNAs in virus-associated cancers. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.04.009] [Reference Citation Analysis]
15 Ursu RG, Damian C, Porumb-Andrese E, Ghetu N, Cobzaru RG, Lunca C, Ripa C, Costin D, Jelihovschi I, Petrariu FD, Iancu LS. Merkel Cell Polyoma Virus and Cutaneous Human Papillomavirus Types in Skin Cancers: Optimal Detection Assays, Pathogenic Mechanisms, and Therapeutic Vaccination. Pathogens 2022;11:479. [PMID: 35456154 DOI: 10.3390/pathogens11040479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Han AY, John MAS. Predictors of Nodal Metastasis in Cutaneous Head and Neck Cancers. Curr Oncol Rep 2022. [PMID: 35394247 DOI: 10.1007/s11912-022-01249-5] [Reference Citation Analysis]
17 Mazziotta C, Lanzillotti C, Gafà R, Touzé A, Durand MA, Martini F, Rotondo JC. The Role of Histone Post-Translational Modifications in Merkel Cell Carcinoma. Front Oncol 2022;12:832047. [PMID: 35350569 DOI: 10.3389/fonc.2022.832047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rasheed K, Moens U, Policastro B, Johnsen JI, Koljonen V, Sihto H, Lui WO, Sveinbjørnsson B. The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma. Int J Mol Sci 2022;23:3702. [PMID: 35409061 DOI: 10.3390/ijms23073702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hoen L, Rudisch C, Wick M, Indenbirken D, Grundhoff A, Wegwitz F, Kalkhof S, Hildebrand J. Osmotic Stress Interferes with DNA Damage Response and H2AX Phosphorylation in Human Keratinocytes. Cells 2022;11:959. [DOI: 10.3390/cells11060959] [Reference Citation Analysis]
20 Durastante V, Conte A, Brollo PP, Biddau C, Graziano M, Bresadola V. Merkel Cell Carcinoma with Gastric Metastasis, a Rare Presentation: Case Report and Literature Review. J Gastrointest Canc. [DOI: 10.1007/s12029-022-00817-z] [Reference Citation Analysis]
21 Casey C, Gallo N, Gallo S, Schwartz SG. Merkel Cell Carcinoma of the Left Eyelid with Metastasis to the Left Submandibular Lymph Nodes: A Case Report and Brief Review. Case Reports in Ophthalmological Medicine 2022;2022:1-3. [DOI: 10.1155/2022/4712301] [Reference Citation Analysis]
22 Bi A, Yang S, Ding Y, Yu Y, Zhan W, Song T. Prognostic Value of Radiotherapy and Chemotherapy in Stage I–III Merkel Cell Carcinoma. Front Med 2022;9:845905. [DOI: 10.3389/fmed.2022.845905] [Reference Citation Analysis]
23 Moens U, Prezioso C, Pietropaolo V. Functional Domains of the Early Proteins and Experimental and Epidemiological Studies Suggest a Role for the Novel Human Polyomaviruses in Cancer. Front Microbiol 2022;13:834368. [DOI: 10.3389/fmicb.2022.834368] [Reference Citation Analysis]
24 Tammaro A, Cantisani C, Chello C, Adebanjo GAR, Lilli L, Farnetani F, Filippi C, Covelli E, Rogges E, Pellacani G. A Challenging Nodular Lesion of the Ear. Medicina 2022;58:269. [DOI: 10.3390/medicina58020269] [Reference Citation Analysis]
25 Ríos-martín JJ, Rodriguez-salas N, Vázquez-doval FJ, Llombart B, Rojas-ferrer N, González-vela MC, Zulueta T, Monteagudo C, Aneiros-fernández J, Beato MJ, Carrillo R, Silva-carmona MY, Ayala M, Gallego E, Rodríguez-peralto JL, Fraga-fernández J, Fernández-figueras MT, Barranco C, Córdoba A, Sanz-zorrilla A, Ferrer B, Fúnez R, Santonja C, Saus C, Idoate MA, Santos-briz A, Onrubia J, Pinedo F, de las Peñas R. Clinical and pathological features of Merkel cell carcinoma: A 4-year follow-up observational retrospective study in Spain. Cancer Epidemiology 2022;76:102081. [DOI: 10.1016/j.canep.2021.102081] [Reference Citation Analysis]
26 Gambichler T, Said S, Abu Rached N, Scheel CH, Susok L, Stranzenbach R, Becker JC. Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-022-03929-y] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Spassova I, Ugurel S, Kubat L, Zimmer L, Terheyden P, Mohr A, Björn Andtback H, Villabona L, Leiter U, Eigentler T, Loquai C, Hassel JC, Gambichler T, Haferkamp S, Mohr P, Pfoehler C, Heinzerling L, Gutzmer R, Utikal JS, Horny K, Schildhaus H, Habermann D, Hoffmann D, Schadendorf D, Becker JC. Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma. J Immunother Cancer 2022;10:e003198. [DOI: 10.1136/jitc-2021-003198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Rastrelli M, Del Fiore P, Russo I, Tartaglia J, Dal Monico A, Cappellesso R, Nicolè L, Piccin L, Fabozzi A, Biffoli B, Di Prata C, Ferrazzi B, Dall'Olmo L, Vecchiato A, Spina R, Russano F, Bezzon E, Cingarlini S, Mazzarotto R, Parisi A, Scarzello G, Pigozzo J, Brambullo T, Tropea S, Vindigni V, Bassetto F, Bertin D, Gregianin M, Dei Tos AP, Cavallin F, Alaibac M, Chiarion-Sileni V, Mocellin S. Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143). Front Oncol 2021;11:737842. [PMID: 34976795 DOI: 10.3389/fonc.2021.737842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Ahmed MM, Cushman CH, DeCaprio JA. Merkel Cell Polyomavirus: Oncogenesis in a Stable Genome. Viruses 2021;14:58. [PMID: 35062263 DOI: 10.3390/v14010058] [Reference Citation Analysis]
30 Thomas M, Mandal A. An Extremely Rare Case of Metastatic Merkel Carcinoma of the Liver. Cureus 2021;13:e19659. [PMID: 34956771 DOI: 10.7759/cureus.19659] [Reference Citation Analysis]
31 Yang JF, You J. Merkel cell polyomavirus and associated Merkel cell carcinoma. Tumour Virus Res 2021;13:200232. [PMID: 34920178 DOI: 10.1016/j.tvr.2021.200232] [Reference Citation Analysis]
32 Leiendecker L, Jung PS, Obenauf AC. Targeting CD56 with an antibody-drug conjugate in Merkel cell carcinoma. Br J Dermatol 2021. [PMID: 34817859 DOI: 10.1111/bjd.20894] [Reference Citation Analysis]
33 Chua TH, Punjabi LS, Khor LY. Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology. Pathogens 2021;10:1410. [PMID: 34832566 DOI: 10.3390/pathogens10111410] [Reference Citation Analysis]
34 Bystricky B, Kohutek F, Miklatkova Z, Sedlacek T, Gal V, Lohajova Behulova R. Spontaneous Regression of Merkel Cell Carcinoma: Case Report. Int Med Case Rep J 2021;14:711-7. [PMID: 34629908 DOI: 10.2147/IMCRJ.S329545] [Reference Citation Analysis]
35 Xu D, Jiang S, He Y, Jin X, Zhao G, Wang B. Development of a therapeutic vaccine targeting Merkel cell polyomavirus capsid protein VP1 against Merkel cell carcinoma. NPJ Vaccines 2021;6:119. [PMID: 34611173 DOI: 10.1038/s41541-021-00382-9] [Reference Citation Analysis]
36 Leiter U, Loquai C, Reinhardt L, Rafei-Shamsabadi D, Gutzmer R, Kaehler K, Heinzerling L, Hassel JC, Glutsch V, Sirokay J, Schlecht N, Rübben A, Gambichler T, Schatton K, Pfoehler C, Franklin C, Terheyden P, Haferkamp S, Mohr P, Bischof L, Livingstone E, Zimmer L, Weichenthal M, Schadendorf D, Meiwes A, Keim U, Garbe C, Becker JC, Ugurel S. Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. J Immunother Cancer 2020;8:e000897. [PMID: 33093156 DOI: 10.1136/jitc-2020-000897] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
37 Esnault C, Leblond V, Martin C, Desgranges A, Baltus CB, Aubrey N, Lakhrif Z, Lajoie L, Lantier L, Clémenceau B, Sarma B, Schrama J, Houben R, Schrama D, Hesbacher S, Gouilleux-Gruart V, Feng Y, Dimitrov D, Guyétant S, Berthon P, Viaud-Massuard MC, Samimi M, Touzé A, Kervarrec T. Adcitmer® , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. Br J Dermatol 2021. [PMID: 34582565 DOI: 10.1111/bjd.20770] [Reference Citation Analysis]
38 Breneman A, Akaike T, Paulson KG, Breneman DL, Nghiem P. Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management. JAAD Case Rep 2021;16:58-61. [PMID: 34522748 DOI: 10.1016/j.jdcr.2021.08.009] [Reference Citation Analysis]
39 Ito S, Chambers JK, Sumi A, Yamashita-Kawanishi N, Omachi T, Haga T, Nakayama H, Uchida K. Involvement of Felis catus papillomavirus type 2 in the tumorigenesis of feline Merkel cell carcinoma. Vet Pathol 2021;:3009858211045440. [PMID: 34510979 DOI: 10.1177/03009858211045440] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kamminga S, van Rijn AL, de Brouwer CS, Rotmans JI, Zaaijer HL, Feltkamp MCW. JC and Human polyomavirus 9 after kidney transplantation: An exploratory serological cohort study. J Clin Virol 2021;143:104944. [PMID: 34450559 DOI: 10.1016/j.jcv.2021.104944] [Reference Citation Analysis]
41 McEvoy A, Martin A, Council ML. Cells to Surgery Quiz: September 2021. J Invest Dermatol 2021;141:e111-7. [PMID: 34420677 DOI: 10.1016/j.jid.2021.07.135] [Reference Citation Analysis]
42 Almadori G, De Corso E, Settimi S, Di Cintio G, Mele DA, Brigato F, Paludetti G, Salgarello M. When is a surgical multidisciplinary approach required in the management of head and neck non-melanoma skin cancer and in advanced head and neck pathologies involving skin? Acta Otorhinolaryngol Ital 2021;41:S145-57. [PMID: 34060530 DOI: 10.14639/0392-100X-suppl.1-41-2021-15] [Reference Citation Analysis]
43 Gujar H, Mehta A, Li HT, Tsai YC, Qiu X, Weisenberger DJ, Jasiulionis MG, In GK, Liang G. Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma. Genome Med 2021;13:130. [PMID: 34399838 DOI: 10.1186/s13073-021-00946-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Gehrcken L, Sauerer T, Schaft N, Dörrie J. T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options. Int J Mol Sci 2021;22:8679. [PMID: 34445385 DOI: 10.3390/ijms22168679] [Reference Citation Analysis]
45 Pietropaolo V, Prezioso C, Moens U. Role of Virus-Induced Host Cell Epigenetic Changes in Cancer. Int J Mol Sci 2021;22:8346. [PMID: 34361112 DOI: 10.3390/ijms22158346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
46 Kassem MA, Hosny KM, Damaševičius R, Eltoukhy MM. Machine Learning and Deep Learning Methods for Skin Lesion Classification and Diagnosis: A Systematic Review. Diagnostics (Basel) 2021;11:1390. [PMID: 34441324 DOI: 10.3390/diagnostics11081390] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Das BK, Kannan A, Nguyen Q, Gogoi J, Zhao H, Gao L. Selective Inhibition of Aurora Kinase A by AK-01/LY3295668 Attenuates MCC Tumor Growth by Inducing MCC Cell Cycle Arrest and Apoptosis. Cancers (Basel) 2021;13:3708. [PMID: 34359608 DOI: 10.3390/cancers13153708] [Reference Citation Analysis]
48 Yusuf MB, McKenzie G, Rattani A, Tennant P, Bumpous J, Miller D, Dunlap N. Merkel Cell Carcinoma of the Head and Neck: Epidemiology, Pathogenesis, Current State of Treatment and Future Directions. Cancers (Basel) 2021;13:3506. [PMID: 34298720 DOI: 10.3390/cancers13143506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Mohammadzadeh H, Babaniamansour S, Majidi M, Zare A, Dehghani Firouzabadi M, Karkon-Shayan S. Merkel cell carcinoma on the right calf in association with chronic lymphocytic leukemia: A case report. Clin Case Rep 2021;9:e04498. [PMID: 34257989 DOI: 10.1002/ccr3.4498] [Reference Citation Analysis]
50 Rasheed K, Sveinbjørnsson B, Moens U. Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins. Virol J 2021;18:139. [PMID: 34217322 DOI: 10.1186/s12985-021-01613-0] [Reference Citation Analysis]
51 Leão I, Marinho J, Costa T. Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report. World J Clin Cases 2021; 9(18): 4829-4836 [PMID: 34222455 DOI: 10.12998/wjcc.v9.i18.4829] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Dellambra E, Carbone ML, Ricci F, Ricci F, Di Pietro FR, Moretta G, Verkoskaia S, Feudi E, Failla CM, Abeni D, Fania L. Merkel Cell Carcinoma. Biomedicines 2021;9:718. [PMID: 34201709 DOI: 10.3390/biomedicines9070718] [Reference Citation Analysis]
53 Vile RG, Melcher A, Pandha H, Harrington KJ, Pulido JS. APOBEC and Cancer Viroimmunotherapy: Thinking the Unthinkable. Clin Cancer Res 2021;27:3280-90. [PMID: 33558423 DOI: 10.1158/1078-0432.CCR-20-1888] [Reference Citation Analysis]
54 Stachyra K, Dudzisz-Śledź M, Bylina E, Szumera-Ciećkiewicz A, Spałek MJ, Bartnik E, Rutkowski P, Czarnecka AM. Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies. Int J Mol Sci 2021;22:6305. [PMID: 34208339 DOI: 10.3390/ijms22126305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
55 Ji X, Sui L, Song K, Lv T, Zhao H, Yao Q. PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer. Cancer Med 2021;10:4743-51. [PMID: 34076351 DOI: 10.1002/cam4.4034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Soliman SHA, Orlacchio A, Verginelli F. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis. Microorganisms 2021;9:1179. [PMID: 34070716 DOI: 10.3390/microorganisms9061179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Hasmat S, Howle JR, Karikios DJ, Carlino MS, Veness MJ. Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience. J Med Imaging Radiat Oncol 2021. [PMID: 34053196 DOI: 10.1111/1754-9485.13243] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Bommareddy K, Kayastha S, Reddy SC. An elderly man with a vascular axillary mass. JAAD Case Rep 2021;14:114-5. [PMID: 34337121 DOI: 10.1016/j.jdcr.2021.05.021] [Reference Citation Analysis]
59 Gambichler T, Abu Rached N, Tannapfel A, Becker JC, Vogt M, Skrygan M, Wieland U, Silling S, Susok L, Stücker M, Meyer T, Stockfleth E, Junker K, Käfferlein HU, Brüning T, Lang K. Expression of Mismatch Repair Proteins in Merkel Cell Carcinoma. Cancers (Basel) 2021;13:2524. [PMID: 34063983 DOI: 10.3390/cancers13112524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Sawada Y, Nakamura M. Daily Lifestyle and Cutaneous Malignancies. Int J Mol Sci 2021;22:5227. [PMID: 34069297 DOI: 10.3390/ijms22105227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 de Melo AC, Santos Thuler LC. Trends in the incidence and morbidity of Merkel cell carcinoma in Brazil. Future Oncol 2021;17:2857-65. [PMID: 33960199 DOI: 10.2217/fon-2020-1313] [Reference Citation Analysis]
62 Egan KM, Kim Y, Bender N, Hodge JM, Coghill AE, Smith-Warner SA, Rollison DE, Teras LR, Grimsrud TK, Waterboer T. Prospective investigation of polyomavirus infection and the risk of adult glioma. Sci Rep 2021;11:9642. [PMID: 33953301 DOI: 10.1038/s41598-021-89133-3] [Reference Citation Analysis]
63 Olsen CM, Pandeya N, Whiteman DC. International Increases in Merkel Cell Carcinoma Incidence Rates between 1997 and 2016. J Invest Dermatol 2021:S0022-202X(21)01214-8. [PMID: 33932460 DOI: 10.1016/j.jid.2021.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Lahman MC, Paulson KG, Nghiem PT, Chapuis AG. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma. J Invest Dermatol 2021;141:1897-905. [PMID: 33863500 DOI: 10.1016/j.jid.2020.12.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Akhtar S, Rajabi-Estarabadi A, Kamath P, Dong J, Nouri K. Cells to Surgery Quiz: April 2021. J Invest Dermatol 2021;141:e43-9. [PMID: 33752814 DOI: 10.1016/j.jid.2021.02.006] [Reference Citation Analysis]
66 Zheng Y, Yu T, Mackey RH, Gayle JA, Wassel CL, Phatak H, Kim R. Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy. Clinicoecon Outcomes Res 2021;13:213-26. [PMID: 33790597 DOI: 10.2147/CEOR.S290768] [Reference Citation Analysis]
67 Läsche M, Urban H, Gallwas J, Gründker C. HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review. Cells 2021;10:714. [PMID: 33807087 DOI: 10.3390/cells10030714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Wu Z, Graf FE, Hirsch HH. Antivirals against human polyomaviruses: Leaving no stone unturned. Rev Med Virol 2021;:e2220. [PMID: 33729628 DOI: 10.1002/rmv.2220] [Reference Citation Analysis]
69 Grubb AF, Hankollari E. Cerebral metastasis of Merkel cell carcinoma following resection with negative margins and adjuvant external beam radiation: a case report. J Med Case Rep 2021;15:118. [PMID: 33714267 DOI: 10.1186/s13256-021-02690-z] [Reference Citation Analysis]
70 Feng Y, Song X, Jia R. Case Report: Favorable Response to the Tyrosine Kinase Inhibitor Apatinib in Recurrent Merkel Cell Carcinoma. Front Oncol 2021;11:625360. [PMID: 33747940 DOI: 10.3389/fonc.2021.625360] [Reference Citation Analysis]
71 Veerabagu S, Cheng B, Higgins HW 2nd. Cells to Surgery Quiz: March 2021. J Invest Dermatol 2021;141:e33-6. [PMID: 33618806 DOI: 10.1016/j.jid.2020.12.018] [Reference Citation Analysis]
72 Gravemeyer J, Lange A, Ritter C, Spassova I, Song L, Picard D, Remke M, Horny K, Sriram A, Gambichler T, Schadendorf D, Hoffmann D, Becker JC. Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition. J Invest Dermatol 2021;141:1675-1686.e4. [PMID: 33600825 DOI: 10.1016/j.jid.2021.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
73 Lango M, Shnayder Y. Surgical Management of Merkel Cell Carcinoma. Otolaryngol Clin North Am 2021;54:357-68. [PMID: 33602514 DOI: 10.1016/j.otc.2020.11.008] [Reference Citation Analysis]
74 Horny K, Gerhardt P, Hebel-Cherouny A, Wülbeck C, Utikal J, Becker JC. Mutational Landscape of Virus- and UV-Associated Merkel Cell Carcinoma Cell Lines Is Comparable to Tumor Tissue. Cancers (Basel) 2021;13:649. [PMID: 33562873 DOI: 10.3390/cancers13040649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
75 Park SY, Doolittle-Amieva C, Moshiri Y, Akaike T, Parvathaneni U, Bhatia S, Zaba LC, Nghiem P. How we treat Merkel cell carcinoma: within and beyond current guidelines. Future Oncol 2021;17:1363-77. [PMID: 33511866 DOI: 10.2217/fon-2020-1036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Park SY, Church C, Alexander NA, Shinohara MM, Paulson KG, Lewis KD, Lee NS, Nghiem P. Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients. JAAD Case Rep 2021;8:28-33. [PMID: 33490342 DOI: 10.1016/j.jdcr.2020.11.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Loke ASW, Longley BJ, Lambert PF, Spurgeon ME. A Novel In Vitro Culture Model System to Study Merkel Cell Polyomavirus-Associated MCC Using Three-Dimensional Organotypic Raft Equivalents of Human Skin. Viruses 2021;13:138. [PMID: 33478104 DOI: 10.3390/v13010138] [Reference Citation Analysis]
78 Glutsch V, Kneitz H, Gesierich A, Goebeler M, Haferkamp S, Becker JC, Ugurel S, Schilling B. Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma. Cancer Immunol Immunother 2021;70:2087-93. [PMID: 33439294 DOI: 10.1007/s00262-020-02832-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
79 Pinzaru I, Tanase A, Enatescu V, Coricovac D, Bociort F, Marcovici I, Watz C, Vlaia L, Soica C, Dehelean C. Proniosomal Gel for Topical Delivery of Rutin: Preparation, Physicochemical Characterization and In Vitro Toxicological Profile Using 3D Reconstructed Human Epidermis Tissue and 2D Cells. Antioxidants (Basel) 2021;10:85. [PMID: 33435216 DOI: 10.3390/antiox10010085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
80 Gupta R, Simonette RA, Doan HQ, Rady PL, Tyring SK. Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment. Br J Dermatol 2021;184:1185-7. [PMID: 33403670 DOI: 10.1111/bjd.19801] [Reference Citation Analysis]
81 Prezioso C, Carletti R, Obregon F, Piacentini F, Manicone AM, Soda G, Moens U, Di Gioia C, Pietropaolo V. Evaluation of Merkel Cell Polyomavirus DNA in Tissue Samples from Italian Patients with Diagnosis of MCC. Viruses 2021;13:61. [PMID: 33466354 DOI: 10.3390/v13010061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Chteinberg E, Wetzels S, Gerritsen W, Temmerman L, van den Oord J, Biessen E, Kurz AK, Winnepenninckx V, Zenke M, Speel EJ, Zur Hausen A. Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro. Ther Adv Med Oncol 2020;12:1758835920975621. [PMID: 33403016 DOI: 10.1177/1758835920975621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Fan K, Spassova I, Gravemeyer J, Ritter C, Horny K, Lange A, Gambichler T, Ødum N, Schrama D, Schadendorf D, Ugurel S, Becker JC. Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53. Oncogene 2021;40:980-96. [PMID: 33311552 DOI: 10.1038/s41388-020-01576-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
84 Gigliano D, Lobo J, Lopes P, Julião I, Lobo F, Azevedo R, Henrique R, Rodrigues Â. Merkel cell carcinoma metastatic to the testis: report of a rare diagnosis and review of the literature. Autops Case Rep 2021;11:e2020198. [PMID: 34277480 DOI: 10.4322/acr.2020.198] [Reference Citation Analysis]
85 Ito S, Chambers JK, Mori C, Sumi A, Omachi T, Nakayama H, Uchida K. Comparative In Vitro and In Vivo Studies on Feline, Canine, and Human Merkel Cell Carcinoma. Vet Pathol 2021;58:276-87. [PMID: 33280569 DOI: 10.1177/0300985820976097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
86 Walsh NM, Cerroni L. Merkel cell carcinoma: A review. J Cutan Pathol 2021;48:411-21. [PMID: 33128463 DOI: 10.1111/cup.13910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
87 Yusuf M, Gaskins J, Mandish S, May ME, Wall W, Fisher W, Tennant P, Jorgensen J, Bumpous J, Dunlap N. Tumor infiltrating lymphocyte grade in Merkel cell carcinoma: relationships with clinical factors and independent prognostic value. Acta Oncol 2020;59:1409-15. [PMID: 32687000 DOI: 10.1080/0284186X.2020.1794033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Gambichler T, Dreißigacker M, Kasakovski D, Skrygan M, Wieland U, Silling S, Gravemeyer J, Melior A, Cherouny A, Stücker M, Stockfleth E, Sand M, Becker JC. Patched 1 expression in Merkel cell carcinoma. J Dermatol 2021;48:64-74. [PMID: 33180347 DOI: 10.1111/1346-8138.15611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Lei V, Petty AJ, Atwater AR, Wolfe SA, MacLeod AS. Skin Viral Infections: Host Antiviral Innate Immunity and Viral Immune Evasion. Front Immunol 2020;11:593901. [PMID: 33240281 DOI: 10.3389/fimmu.2020.593901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Effraimidou E, Kofina K, Giatromanolaki A, Chatzipantelis P, Karanikas M, Lyratzopoulos N. Primary ectopic Merkel cell carcinoma without skin involvement-report of a case with prolonged survival. J Surg Case Rep 2020;2020:rjaa390. [PMID: 33163153 DOI: 10.1093/jscr/rjaa390] [Reference Citation Analysis]
91 Prezioso C, Bianchi M, Obregon F, Ciotti M, Sarmati L, Andreoni M, Palamara AT, Pascarella S, Moens U, Pietropaolo V. Structural Analysis of Merkel Cell Polyomavirus (MCPyV) Viral Capsid Protein 1 (VP1) in HIV-1 Infected Individuals. Int J Mol Sci 2020;21:E7998. [PMID: 33121182 DOI: 10.3390/ijms21217998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Kotelnikova EF, Laus M, Croce A. Evidence and Considerations on Treatment of Small Size Merkel Cell Head and Neck Carcinoma. Int Arch Otorhinolaryngol 2020;24:e487-91. [PMID: 33101516 DOI: 10.1055/s-0040-1709114] [Reference Citation Analysis]
93 Saribas S, Safak M. A Comprehensive Proteomics Analysis of the JC Virus (JCV) Large and Small Tumor Antigen Interacting Proteins: Large T Primarily Targets the Host Protein Complexes with V-ATPase and Ubiquitin Ligase Activities While Small t Mostly Associates with Those Having Phosphatase and Chromatin-Remodeling Functions. Viruses 2020;12:E1192. [PMID: 33092197 DOI: 10.3390/v12101192] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Hamilton G. Avelumab: search for combinations of immune checkpoint inhibition with chemotherapy. Expert Opin Biol Ther 2021;21:311-22. [PMID: 32954871 DOI: 10.1080/14712598.2021.1825679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
95 Song L, Bretz AC, Gravemeyer J, Spassova I, Muminova S, Gambichler T, Sriram A, Ferrone S, Becker JC. The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells. J Invest Dermatol 2021;141:903-912.e4. [PMID: 33002502 DOI: 10.1016/j.jid.2020.08.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
96 Samimi M, Kervarrec T, Touze A. Immunobiology of Merkel cell carcinoma. Curr Opin Oncol 2020;32:114-21. [PMID: 31972727 DOI: 10.1097/CCO.0000000000000608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
97 Nwogu N, Ortiz LE, Kwun HJ. Merkel Cell Polyomavirus Large T Antigen Unique Domain Regulates Its Own Protein Stability and Cell Growth. Viruses 2020;12:E1043. [PMID: 32962090 DOI: 10.3390/v12091043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Nwogu N, Ortiz LE, Whitehouse A, Kwun HJ. Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion. J Virol 2020;94:e00786-20. [PMID: 32669331 DOI: 10.1128/JVI.00786-20] [Reference Citation Analysis]
99 Stege HM, Bradfisch F, Fleischer MI, Mohr P, Ugurel S, Terheyden P, Thiem A, Kiecker F, Leiter U, Becker JC, Grabbe S, Loquai C. Retrospective Multicenter Analysis of the Outcome of a Re-Induction with Immune Checkpoint Inhibitors in Advanced Merkel Cell Carcinoma. SN Compr Clin Med 2020;2:2202-7. [DOI: 10.1007/s42399-020-00488-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
100 Czech-Sioli M, Günther T, Therre M, Spohn M, Indenbirken D, Theiss J, Riethdorf S, Qi M, Alawi M, Wülbeck C, Fernandez-Cuesta I, Esmek F, Becker JC, Grundhoff A, Fischer N. High-resolution analysis of Merkel Cell Polyomavirus in Merkel Cell Carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanisms. PLoS Pathog 2020;16:e1008562. [PMID: 32833988 DOI: 10.1371/journal.ppat.1008562] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
101 Kok DL, Wang A, Xu W, Chua MST, Guminski A, Veness M, Howle J, Tothill R, Kichendasse G, Poulsen M, Sandhu S, Fogarty G. The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentary. Asia Pac J Clin Oncol 2020;16:312-9. [PMID: 32757453 DOI: 10.1111/ajco.13407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
102 Akaike G, Akaike T, Fadl SA, Lachance K, Nghiem P, Behnia F. Imaging of Merkel Cell Carcinoma: What Imaging Experts Should Know. Radiographics 2019;39:2069-84. [PMID: 31697628 DOI: 10.1148/rg.2019190102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
103 Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, Cavallo F, Giudice G, Stucci LS, Porta C, Tucci M. Non-Melanoma Skin Cancers: Biological and Clinical Features. Int J Mol Sci 2020;21:E5394. [PMID: 32751327 DOI: 10.3390/ijms21155394] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
104 Singh N, Alexander NA, Lachance K, Lewis CW, McEvoy A, Akaike G, Byrd D, Behnia S, Bhatia S, Paulson KG, Nghiem P. Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patients. J Am Acad Dermatol 2021;84:330-9. [PMID: 32707254 DOI: 10.1016/j.jaad.2020.07.065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
105 Mendoza MD, Santonja C, Gonzalez-Vela C, Concha A, Iglesias Pena N, Andrés-Esteban EM, Vaque JP, Cereceda L, Pajares R, Kutzner H, Requena L, Piris MA. The presence of Merkel cell carcinoma polyomavirus is associated with a distinct phenotype in neoplastic Merkel cell carcinoma cells and their tissue microenvironment. PLoS One 2020;15:e0232517. [PMID: 32687503 DOI: 10.1371/journal.pone.0232517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Pietropaolo V, Prezioso C, Moens U. Merkel Cell Polyomavirus and Merkel Cell Carcinoma. Cancers (Basel) 2020;12:E1774. [PMID: 32635198 DOI: 10.3390/cancers12071774] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
107 Bryant MK, Ward C, Gaber CE, Strassle PD, Ollila DW, Laks S. Decreased survival and increased recurrence in Merkel cell carcinoma significantly linked with immunosuppression. J Surg Oncol 2020. [PMID: 32562583 DOI: 10.1002/jso.26048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
108 Torre-Castro J, Mendoza-Cembranos MD, Díaz-Recuero JL, Requena L, Santonja C. New-onset subcutaneous nodules on the leg. Int J Dermatol 2020;59:e352-3. [PMID: 32530091 DOI: 10.1111/ijd.14986] [Reference Citation Analysis]
109 Liu W, Kim GB, Krump NA, Zhou Y, Riley JL, You J. Selective reactivation of STING signaling to target Merkel cell carcinoma. Proc Natl Acad Sci U S A 2020;117:13730-9. [PMID: 32482869 DOI: 10.1073/pnas.1919690117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
110 Sahi H, Their J, Gissler M, Koljonen V. Merkel Cell Carcinoma Treatment in Finland in 1986-2016-A Real-World Data Study. Cancers (Basel) 2020;12:E1224. [PMID: 32414207 DOI: 10.3390/cancers12051224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Song Y, Azari FS, Tang R, Shannon AB, Miura JT, Fraker DL, Karakousis GC. Patterns of Metastasis in Merkel Cell Carcinoma. Ann Surg Oncol 2021;28:519-29. [PMID: 32405979 DOI: 10.1245/s10434-020-08587-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Young S, Oh J, Bukhari H, Ng T, Chau N, Tran E. Primary Parotid Merkel Type Small Cell Neuroendocrine Carcinoma with Oligometastasis to the Brain and Adrenal Gland: Case Report and Review of Literature. Head Neck Pathol 2021;15:311-8. [PMID: 32350808 DOI: 10.1007/s12105-020-01164-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Orouji E, Peitsch WK, Orouji A, Houben R, Utikal J. Unique Role of Histone Methyltransferase PRDM8 in the Tumorigenesis of Virus-Negative Merkel Cell Carcinoma. Cancers (Basel) 2020;12:E1057. [PMID: 32344701 DOI: 10.3390/cancers12041057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma. J Invest Dermatol 2020;140:2146-2156.e4. [PMID: 32304704 DOI: 10.1016/j.jid.2020.02.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
115 Boyer M, Cayrefourcq L, Dereure O, Meunier L, Becquart O, Alix-Panabières C. Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma. Cancers (Basel) 2020;12:E960. [PMID: 32295074 DOI: 10.3390/cancers12040960] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
116 Tabachnick-Cherny S, Pulliam T, Church C, Koelle DM, Nghiem P. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development. Mol Carcinog 2020;59:807-21. [PMID: 32219902 DOI: 10.1002/mc.23190] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
117 Ingraham BS, Klarich KW, Anavekar NS, Grogan M. Metastatic Merkel Cell Carcinoma Resulting in Complete Heart Block. JACC CardioOncol 2020;2:131-4. [PMID: 34396219 DOI: 10.1016/j.jaccao.2020.01.008] [Reference Citation Analysis]
118 Arora R, Gupta K, Vijaykumar A, Krishna S. DETECTing Merkel Cell Polyomavirus in Merkel Tumors. Front Mol Biosci 2020;7:10. [PMID: 32118036 DOI: 10.3389/fmolb.2020.00010] [Reference Citation Analysis]
119 Fernandez-flores A, Varela-vazquez A, Suárez Peñaranda JM, Mayan MD, Fonseca E. Expression of Connexin 43 in 32 Cases of Merkel Cell Carcinoma. The American Journal of Dermatopathology 2020;42:178-85. [DOI: 10.1097/dad.0000000000001591] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Goldust M, Heinz J, Gupta M, Grabbe S. Merkel cell carcinoma-derived Erysipelas carcinomatosum. Dermatol Ther 2020;33:e13287. [PMID: 32118331 DOI: 10.1111/dth.13287] [Reference Citation Analysis]
121 Fan K, Zebisch A, Horny K, Schrama D, Becker JC. Highly Expressed miR-375 is not an Intracellular Oncogene in Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma. Cancers (Basel) 2020;12:E529. [PMID: 32106526 DOI: 10.3390/cancers12030529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
122 Liu W, Krump NA, Herlyn M, You J. Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity. Biology (Basel) 2020;9:E35. [PMID: 32093022 DOI: 10.3390/biology9020035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
123 Del Marmol V, Lebbé C. New perspectives in Merkel cell carcinoma. Curr Opin Oncol 2019;31:72-83. [PMID: 30694842 DOI: 10.1097/CCO.0000000000000508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
124 Slevin MK, Wollison BM, Powers W, Burns RT, Patel N, Ducar MD, Starrett GJ, Garcia EP, Manning DK, Cheng J, Hanna GJ, Kaye KM, Van Hummelen P, Nag A, Thorner AR, DeCaprio JA, MacConaill LE. ViroPanel: Hybrid Capture and Massively Parallel Sequencing for Simultaneous Detection and Profiling of Oncogenic Virus Infection and Tumor Genome. J Mol Diagn 2020;22:476-87. [PMID: 32068070 DOI: 10.1016/j.jmoldx.2019.12.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
125 Gambichler T, Ardabili S, Lang K, Dreißigacker M, Scheel C, Brand-Saberi B, Skrygan M, Stockfleth E, Käfferlein HU, Brüning T, Becker JC. Expression of Lefty predicts Merkel cell carcinoma-specific death. J Eur Acad Dermatol Venereol 2020;34:2016-20. [PMID: 32022949 DOI: 10.1111/jdv.16271] [Reference Citation Analysis]
126 Boyer M, Cayrefourcq L, Garima F, Foulongne V, Dereure O, Alix-Panabières C. Circulating Tumor Cell Detection and Polyomavirus Status in Merkel Cell Carcinoma. Sci Rep 2020;10:1612. [PMID: 32005907 DOI: 10.1038/s41598-020-58572-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
127 Csoboz B, Rasheed K, Sveinbjørnsson B, Moens U. Merkel cell polyomavirus and non-Merkel cell carcinomas: guilty or circumstantial evidence? APMIS 2020;128:104-20. [PMID: 31990105 DOI: 10.1111/apm.13019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
128 Kervarrec T, Aljundi M, Appenzeller S, Samimi M, Maubec E, Cribier B, Deschamps L, Sarma B, Sarosi EM, Berthon P, Levy A, Bousquet G, Tallet A, Touzé A, Guyétant S, Schrama D, Houben R. Polyomavirus-Positive Merkel Cell Carcinoma Derived from a Trichoblastoma Suggests an Epithelial Origin of this Merkel Cell Carcinoma. J Invest Dermatol 2020;140:976-85. [PMID: 31759946 DOI: 10.1016/j.jid.2019.09.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
129 Smirnov A, Anemona L, Novelli F, Piro CM, Annicchiarico-Petruzzelli M, Melino G, Candi E. p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer. Int J Mol Sci 2019;20:E5781. [PMID: 31744230 DOI: 10.3390/ijms20225781] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
130 Tetzlaff MT, Harms PW. Danger is only skin deep: aggressive epidermal carcinomas. An overview of the diagnosis, demographics, molecular-genetics, staging, prognostic biomarkers, and therapeutic advances in Merkel cell carcinoma. Mod Pathol 2020;33:42-55. [PMID: 31676786 DOI: 10.1038/s41379-019-0394-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
131 Nghiem P, Park SY. Less Toxic, More Effective Treatment—A Win-Win for Patients With Merkel Cell Carcinoma. JAMA Dermatol 2019;155:1223. [DOI: 10.1001/jamadermatol.2019.2584] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
132 Schmerling RA, Casas JG, Cinat G, Ospina FEG, Kassuga LEBP, Tlahuel JLM, Mazzuoccolo LD. Burden of Disease, Early Diagnosis, and Treatment of Merkel Cell Carcinoma in Latin America. J Glob Oncol 2018;4:1-11. [PMID: 30085832 DOI: 10.1200/JGO.18.00041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
133 Arora R, Rekhi B, Chandrani P, Krishna S, Dutt A. Merkel cell polyomavirus is implicated in a subset of Merkel cell carcinomas, in the Indian subcontinent. Microb Pathog 2019;137:103778. [PMID: 31600537 DOI: 10.1016/j.micpath.2019.103778] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
134 Lilo MT, Chen Y, LeBlanc RE. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma. Am J Surg Pathol 2018;42:1541-8. [PMID: 30080705 DOI: 10.1097/PAS.0000000000001136] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 10.3] [Reference Citation Analysis]
135 Terheyden P, Mohr A, Langan EA. [Immune checkpoint inhibition in Merkel cell carcinoma]. Hautarzt 2019;70:684-90. [PMID: 31468071 DOI: 10.1007/s00105-019-4465-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
136 Principe DR, Clark JI, Emami B, Borowicz S. Combined radio-immunotherapy leads to complete clinical regression of stage IV Merkel cell carcinoma. BMJ Case Rep 2019;12:e230518. [PMID: 31439556 DOI: 10.1136/bcr-2019-230518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Knepper TC, Montesion M, Russell JS, Sokol ES, Frampton GM, Miller VA, Albacker LA, McLeod HL, Eroglu Z, Khushalani NI, Sondak VK, Messina JL, Schell MJ, DeCaprio JA, Tsai KY, Brohl AS. The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy. Clin Cancer Res 2019;25:5961-71. [PMID: 31399473 DOI: 10.1158/1078-0432.CCR-18-4159] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
138 Fan K, Gravemeyer J, Ritter C, Rasheed K, Gambichler T, Moens U, Shuda M, Schrama D, Becker JC. MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma. J Invest Dermatol 2020;140:56-65.e3. [PMID: 31283928 DOI: 10.1016/j.jid.2019.06.135] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
139 Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Herfs M, Touzé A, Samimi M, Guyétant S. Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma. Mod Pathol 2019;32:1605-16. [PMID: 31201352 DOI: 10.1038/s41379-019-0288-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
140 Tenea D, Dinkel J, Becker JC, van der Walt E. Merkel Cell Carcinoma of the Head in a Young African Albino Woman with HIV/HTLV-1 Coinfection Associated with Multiple Squamous Cell Carcinomas. Case Rep Dermatol 2019;11:113-22. [PMID: 31143109 DOI: 10.1159/000499898] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Zaremba A, Chorti E, Jockenhöfer F, Bolz S, Sirin S, Glas M, Becker JC, Ugurel S, Roesch A, Schadendorf D, Livingstone E, Hagenacker T, Zimmer L. Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors? J Immunother Cancer 2019;7:141. [PMID: 31142383 DOI: 10.1186/s40425-019-0626-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
142 Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C. S2k-Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) - Update 2018. J Dtsch Dermatol Ges 2019;17:562-77. [PMID: 31115985 DOI: 10.1111/ddg.13841_g] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Harms PW, Harms KL, Moore PS, DeCaprio JA, Nghiem P, Wong MKK, Brownell I; International Workshop on Merkel Cell Carcinoma Research (IWMCC) Working Group. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. Nat Rev Clin Oncol 2018;15:763-76. [PMID: 30287935 DOI: 10.1038/s41571-018-0103-2] [Cited by in Crossref: 105] [Cited by in F6Publishing: 91] [Article Influence: 35.0] [Reference Citation Analysis]
144 Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C. S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - update 2018. J Dtsch Dermatol Ges 2019;17:562-76. [PMID: 31056838 DOI: 10.1111/ddg.13841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
145 Dickinson SE, Wondrak GT. TLR4 in skin cancer: From molecular mechanisms to clinical interventions. Mol Carcinog 2019;58:1086-93. [PMID: 31020719 DOI: 10.1002/mc.23016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
146 Laikova KV, Oberemok VV, Krasnodubets AM, Gal'chinsky NV, Useinov RZ, Novikov IA, Temirova ZZ, Gorlov MV, Shved NA, Kumeiko VV, Makalish TP, Bessalova EY, Fomochkina II, Esin AS, Volkov ME, Kubyshkin AV. Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs. Molecules 2019;24:E1516. [PMID: 30999681 DOI: 10.3390/molecules24081516] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
147 Ugurel S, Spassova I, Wohlfarth J, Drusio C, Cherouny A, Melior A, Sucker A, Zimmer L, Ritter C, Schadendorf D, Becker JC. MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series. Cancer Immunol Immunother 2019;68:983-90. [DOI: 10.1007/s00262-019-02341-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
148 Godeau M, Pages-Laurent C, Severino-Freire M, Guinard E, Tauber M, Larrieu-Ciron D, Lamant L, Evrard SM, Riffaud L, Sibaud V, Boulinguez S, Meyer N. A case of merkel leptomeningeal evolution after complete remission upon anti-PD-1 treatment. Eur J Cancer 2019;113:55-7. [PMID: 30981092 DOI: 10.1016/j.ejca.2019.03.009] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Jenkins LN, Howle JR, Veness MJ. Sentinel lymph node biopsy in clinically node‐negative Merkel cell carcinoma: the Westmead Hospital experience. ANZ Journal of Surgery 2017;89:520-3. [DOI: 10.1111/ans.15228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
150 Garbutcheon‐singh KB, Veness MJ. The role of radiotherapy in the management of non‐melanoma skin cancer. Australas J Dermatol 2019;60:265-72. [DOI: 10.1111/ajd.13025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
151 Saggini A, Lora V, Baldelli R, Orlandi A, Cota C. Merkel Cell Polyomavirus-Positive Panniculitic Merkel Cell Carcinoma: A Rare Neoplasm of Unknown Histogenesis. Am J Dermatopathol 2020;42:151-3. [PMID: 30908296 DOI: 10.1097/DAD.0000000000001404] [Reference Citation Analysis]
152 Sheu JC, Tran J, Rady PL, Dao H Jr, Tyring SK, Nguyen HP. Polyomaviruses of the skin: integrating molecular and clinical advances in an emerging class of viruses. Br J Dermatol 2019;180:1302-11. [PMID: 30585627 DOI: 10.1111/bjd.17592] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
153 Li N, Wang G, Jiang X, Huang M, Tian H, Xuan F, Zhang Y, Lv Y, Hu M, Wang Z, Ren P, Xu M. Merkel cell carcinoma metastatic to cervical lymph node in a patient with rheumatoid arthritis: a case report. Onco Targets Ther 2019;12:1395-400. [PMID: 30863106 DOI: 10.2147/OTT.S188403] [Reference Citation Analysis]
154 Miyazawa H, Shimauchi T, Hashizume H, Masuda Y, Aoshima M, Ito T, Tokura Y. Voriconazole-photoinduced polyomavirus-negative Merkel cell carcinoma. J Dermatol 2019;46:e287-8. [PMID: 30859619 DOI: 10.1111/1346-8138.14849] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
155 Villani A, Fabbrocini G, Costa C, Carmela Annunziata M, Scalvenzi M. Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies. Dermatol Ther (Heidelb). 2019;9:209-222. [PMID: 30820877 DOI: 10.1007/s13555-019-0288-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
156 Lucas RM, Yazar S, Young AR, Norval M, de Gruijl FR, Takizawa Y, Rhodes LE, Sinclair CA, Neale RE. Human health in relation to exposure to solar ultraviolet radiation under changing stratospheric ozone and climate. Photochem Photobiol Sci 2019;18:641-80. [PMID: 30810559 DOI: 10.1039/c8pp90060d] [Cited by in Crossref: 70] [Cited by in F6Publishing: 26] [Article Influence: 23.3] [Reference Citation Analysis]
157 Hanai S, Shimauchi T, Kageyama R, Aoshima M, Ito T, Tokura Y. Unknown primary Merkel cell carcinoma responding well to first-line treatment with avelumab. J Dermatol 2019;46:e273-5. [PMID: 30802319 DOI: 10.1111/1346-8138.14827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
158 Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM, Reddy SA, Boulmay BC, Riker AI, Burgess MA, Hanks BA, Olencki T, Margolin K, Lundgren LM, Soni A, Ramchurren N, Church C, Park SY, Shinohara MM, Salim B, Taube JM, Bird SR, Ibrahim N, Fling SP, Homet Moreno B, Sharon E, Cheever MA, Topalian SL. Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy. J Clin Oncol 2019;37:693-702. [PMID: 30726175 DOI: 10.1200/JCO.18.01896] [Cited by in Crossref: 148] [Cited by in F6Publishing: 91] [Article Influence: 49.3] [Reference Citation Analysis]
159 D'Angelo SP, Hunger M, Brohl AS, Nghiem P, Bhatia S, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbé C, Lewis KD, Linette GP, Milella M, Schlichting M, Hennessy MH, Bharmal M. Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma. Cancer Immunol Immunother 2019;68:609-18. [PMID: 30721341 DOI: 10.1007/s00262-018-02295-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
160 Drusio C, Becker JC, Schadendorf D, Ugurel S. [Merkel cell carcinoma]. Hautarzt 2019;70:215-27. [PMID: 30701288 DOI: 10.1007/s00105-019-4360-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
161 Gambichler T, Schmitt K, Rüddel I, Dreibigacker M, Stockfleth E, Becker JC. Decreased 5-hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease-specific death. Br J Dermatol 2019;181:389-90. [PMID: 30703276 DOI: 10.1111/bjd.17705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
162 Arora R, Vats A, Chimankar V. MCV Truncated Large T antigen interacts with BRD4 in tumors. Matters (Zur) 2019;2019. [PMID: 32395462 DOI: 10.19185/matters.201811000004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Riethdorf S, Hildebrandt L, Heinzerling L, Heitzer E, Fischer N, Bergmann S, Mauermann O, Waldispühl-Geigl J, Coith C, Schön G, Peine S, Schuler G, Speicher MR, Moll I, Pantel K. Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma. Clin Chem 2019;65:462-72. [PMID: 30626636 DOI: 10.1373/clinchem.2018.297028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
164 Park DE, Cheng J, Berrios C, Montero J, Cortés-Cros M, Ferretti S, Arora R, Tillgren ML, Gokhale PC, DeCaprio JA. Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response. Proc Natl Acad Sci U S A 2019;116:1027-32. [PMID: 30598450 DOI: 10.1073/pnas.1818798116] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
165 Tétu P, Baroudjian B, Madelaine I, Delyon J, Lebbé C. [Update in treatment for Merkel Cell Carcinoma and clinical practice guide]. Bull Cancer 2019;106:64-72. [PMID: 30579571 DOI: 10.1016/j.bulcan.2018.11.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Siref A, Hendifar A, Balzer B. Primary Visceral Merkel Cell Carcinoma: A Case Report and Review of the Literature. The American Journal of Dermatopathology 2018;40:927-9. [DOI: 10.1097/dad.0000000000001194] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
167 Haley CT, Mui UN, Vangipuram R, Rady PL, Tyring SK. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention: Papillomaviruses and Merkel cell polyomavirus. J Am Acad Dermatol 2019;81:1-21. [PMID: 30502418 DOI: 10.1016/j.jaad.2018.09.062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
168 Miller NJ, Church CD, Fling SP, Kulikauskas R, Ramchurren N, Shinohara MM, Kluger HM, Bhatia S, Lundgren L, Cheever MA, Topalian SL, Nghiem P. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy. J Immunother Cancer 2018;6:131. [PMID: 30482247 DOI: 10.1186/s40425-018-0450-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
169 Bhat VK, Bernhart E, Plastira I, Fan K, Ghaffari-Tabrizi-Wizsy N, Wadsack C, Rechberger G, Eichmann T, Asslaber M, Spassova I, Verhaegen ME, Malle E, Becker JC, Sattler W. Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation. J Invest Dermatol 2019;139:807-17. [PMID: 30399362 DOI: 10.1016/j.jid.2018.10.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
170 Giraldo NA, Nguyen P, Engle EL, Kaunitz GJ, Cottrell TR, Berry S, Green B, Soni A, Cuda JD, Stein JE, Sunshine JC, Succaria F, Xu H, Ogurtsova A, Danilova L, Church CD, Miller NJ, Fling S, Lundgren L, Ramchurren N, Yearley JH, Lipson EJ, Cheever M, Anders RA, Nghiem PT, Topalian SL, Taube JM. Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab. J Immunother Cancer 2018;6:99. [PMID: 30285852 DOI: 10.1186/s40425-018-0404-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 16.0] [Reference Citation Analysis]
171 Gaglia MM, Munger K. More than just oncogenes: mechanisms of tumorigenesis by human viruses. Curr Opin Virol 2018;32:48-59. [PMID: 30268926 DOI: 10.1016/j.coviro.2018.09.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
172 Rastrelli M, Ferrazzi B, Cavallin F, Chiarion Sileni V, Pigozzo J, Fabozzi A, Tropea S, Vecchiato A, Costa A, Parisi A, Rossi CR, Del Fiore P, Alaibac M. Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 Patients. Cancers (Basel) 2018;10:E350. [PMID: 30249978 DOI: 10.3390/cancers10100350] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
173 Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N, Thomas H, Colunga AG, Iyer JG, Yee C, Kulikauskas R, Koelle DM, Pierce RH, Bielas JH, Greenberg PD, Bhatia S, Gottardo R, Nghiem P, Chapuis AG. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat Commun 2018;9:3868. [PMID: 30250229 DOI: 10.1038/s41467-018-06300-3] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 25.8] [Reference Citation Analysis]
174 Wardhani LO, Matsushita M, Iwasaki T, Kuwamoto S, Nonaka D, Nagata K, Kato M, Kitamura Y, Hayashi K. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma. Hum Pathol 2019;84:52-61. [PMID: 30240768 DOI: 10.1016/j.humpath.2018.09.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
175 Kearney M, Thokagevistk K, Boutmy E, Bharmal M. Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States. Journal of Medical Economics 2018;21:1159-71. [DOI: 10.1080/13696998.2018.1517089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
176 Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 2018;31:1770-86. [PMID: 30140036 DOI: 10.1038/s41379-018-0110-y] [Cited by in Crossref: 288] [Cited by in F6Publishing: 260] [Article Influence: 72.0] [Reference Citation Analysis]
177 Purdie KJ, Proby CM, Rizvi H, Griffin H, Doorbar J, Sommerlad M, Feltkamp MC, der Meijden EV, Inman GJ, South AP, Leigh IM, Harwood CA. The Role of Human Papillomaviruses and Polyomaviruses in BRAF-Inhibitor Induced Cutaneous Squamous Cell Carcinoma and Benign Squamoproliferative Lesions. Front Microbiol 2018;9:1806. [PMID: 30154763 DOI: 10.3389/fmicb.2018.01806] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
178 Fan K, Ritter C, Nghiem P, Blom A, Verhaegen ME, Dlugosz A, Ødum N, Woetmann A, Tothill RW, Hicks RJ, Sand M, Schrama D, Schadendorf D, Ugurel S, Becker JC. Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma. Clin Cancer Res 2018;24:5873-82. [PMID: 30061360 DOI: 10.1158/1078-0432.CCR-18-1184] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
179 Chteinberg E, Rennspiess D, Sambo R, Tauchmann S, Kelleners-Smeets NWJ, Winnepenninckx V, Speel EJ, Kurz AK, Zenke M, Zur Hausen A. Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma. Oncotarget 2018;9:29565-73. [PMID: 30038704 DOI: 10.18632/oncotarget.25619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
180 Konstatinell A, Coucheron DH, Sveinbjørnsson B, Moens U. MicroRNAs as Potential Biomarkers in Merkel Cell Carcinoma. Int J Mol Sci 2018;19:E1873. [PMID: 29949882 DOI: 10.3390/ijms19071873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
181 Shirley M. Avelumab: A Review in Metastatic Merkel Cell Carcinoma. Targ Oncol 2018;13:409-16. [DOI: 10.1007/s11523-018-0571-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
182 Stang A, Becker JC, Nghiem P, Ferlay J. The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment. Eur J Cancer 2018;94:47-60. [PMID: 29533867 DOI: 10.1016/j.ejca.2018.02.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 11.0] [Reference Citation Analysis]
183 Tetzlaff MT, Nagarajan P. Update on Merkel Cell Carcinoma. Head Neck Pathol. 2018;12:31-43. [PMID: 29556962 DOI: 10.1007/s12105-018-0898-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
184 Grabbe S, Terheyden P, Becker JC. Checkpoint-Inhibitor nun auch zur Therapie des metastasierten Merkelzellkarzinoms zugelassen. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2018;16:394-5. [DOI: 10.1111/ddg.13432] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Becker JC, Stang A, Hausen AZ, Fischer N, DeCaprio JA, Tothill RW, Lyngaa R, Hansen UK, Ritter C, Nghiem P, Bichakjian CK, Ugurel S, Schrama D. Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunol Immunother 2018;67:341-51. [PMID: 29188306 DOI: 10.1007/s00262-017-2099-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
186 Stelow EB, Yaziji H. Immunohistochemistry, carcinomas of unknown primary, and incidence rates. Semin Diagn Pathol. 2018;35:143-152. [PMID: 29224972 DOI: 10.1053/j.semdp.2017.11.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]